Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 231 results found. Search for [ oxford-astrazeneca vaccine approval ]

Results 1 to 21 of 231
Reuters
March 4, 2021
Government data shows that only 10% of about 12.6 million people immunised in India have taken the COVAXIN shot, which was found to be 81% effective in an interim analysis of the late-stage trial, its developer Bharat Biotech said


BusinessToday.In
March 1, 2021
The government, in this phase, will vaccinate people over 60 and individuals over 45 with comorbidities to rein in the rising number of more infectious virus strains leading to a spurt in COVID-19 cases in some states


Reuters
February 25, 2021
India has vaccinated more than 10.5 million health and front-line workers since beginning its immunisation campaign on January 16


BusinessToday.In
February 24, 2021
Biological E has tied up with vaccine maker Johnson & Johnson and Baylor College of Medicine in Houston. And, it plans to start the Phase 3 trial of the candidate licensed from Baylor College next week


Reuters
February 19, 2021
Symptoms, as reported in clinical trials for the AstraZeneca shot, can include a high temperature or headache and are a normal sign that the body is generating an immune response


BusinessToday.In
February 19, 2021
In this meeting, the NTAGI will review the World Health Organisation's (WHO) recommendation to extend the gap between two doses of the AstraZeneca- Oxford vaccine from 4 weeks to 8-12 weeks


BusinessToday.In
February 16, 2021
Astrazeneca Pharma India share opened with a gain of 3.26% at Rs 3,700 today. On NSE, the share rose 11.50% to Rs 4,050 against previous close of Rs 3,630.75


BusinessToday.In
February 16, 2021
Serum Institute has applied for registration with Health Canada with the help of Toronto-based Verity Pharmaceuticals, Adar Poonawalla said


Chitranjan Kumar
February 15, 2021
COVID-19 vaccine: The AstraZeneca-Oxford product is a viral vectored vaccine called ChAdOx1-S [recombinant], which is being produced at several manufacturing sites, as well as in the Republic of Korea and India


Reuters
February 15, 2021
South Korea had said it would complete vaccinations on 1.3 million people by the first quarter of this year with AstraZeneca shots, but it slashed the target sharply to 750,000


BusinessToday.In
February 12, 2021
Chhattisgarh CM had raised two primary concerns regarding Covaxin -- inhibitions on incomplete trials and absence of \"expiration date\". Dr Vardhan says vaccine approved after due evaluation of pre-clinical and clinical trial data and that expiry date is mentioned on its label


Reuters
February 9, 2021
Another candidate, developed by CanSino Biologics Inc(CanSinoBIO), has also completed clinical trials in the South Asian nation of 220 million people


Joe C Mathew
February 9, 2021
The enhanced trade partnership is expected to address several trade barriers that currently exist. Britain is keen to see India reduces barriers on import of agriculture and food items


BusinessToday.In
New Delhi, February 6, 2021
The Reserve Bank of India projected Indian economy to grow as much as 26.2 per cent during the first half of the upcoming financial year; Drugmaker AstraZeneca PLC said on Friday it had applied for approval in Japan of its COVID-19 vaccine; Ministry of Housing and Urban Affairs (MoHUA) has signed a memorandum of understanding (MoU) with Zomato for empowering street food vendors. Watch this and more on News Blast.Also Read: Oxford-Astrazeneca COVID-19 vaccine effective against mutant UK variant


PTI
February 6, 2021
Andrew Pollard of Oxford University, which helped develop the AstraZeneca vaccine, says the shot also appears to reduce the amount of virus in people infected with COVID-19


Rashi Bisaria
New Delhi, February 6, 2021
Covid-19 vaccine: AstraZeneca applies for approval in JapanDrugmaker AstraZeneca PLC said on Friday it had applied for approval in Japan of its COVID-19 vaccine, making it the second pharmaceutical firm to do so after Pfizer Inc. The Japanese government in December signed a contract to procure 120 million doses of the AstraZeneca vaccine, enough for 60 million people. Aviation sector showing positive signs but still in eye of storm: Airbus India presidentThe Indian aviation sector is showi...


Reuters
February 5, 2021
AstraZeneca started clinical trials in Japan last summer, recruiting 256 volunteers


BusinessToday.In
February 4, 2021
The Union Health Ministry has claimed that India has become the fastest country in the world to reach the 4 million vaccination mark in 18 days


BusinessToday.In
February 3, 2021
The study published in 'PrePrints with the The Lancet' reveals that administration of the Oxford-AstraZeneca vaccine has 'substantially reduced' transmission of the virus


PTI
February 2, 2021
Union Minister of State for Health Ashwini Choubey was responding to a question on whether the government has finalised a pricing and supply agreement with the Serum Institute of India Limited for COVID-19 vaccines


PAGES 1 OF 12  12345